LEBLANC LEONARD J
Known title: DirectorCIK: 0001244065
Associated companies
Transaction History
| AXTI | ▼ Sell | Open Market | 4,000 | $384K | 8/17/2026 | View on chart |
| AXTI | ▼ Sell | Open Market | 2,000 | $177K | 8/7/2026 | View on chart |
| AXTI | ▼ Sell | Open Market | 500 | $45K | 6/10/2026 | View on chart |
| AXTI | ▲ Buy | Grant | 754 | — | 6/4/2026 | View on chart |
| AXTI | ▼ Sell | Open Market | 3,637 | $31K | 11/7/2025 | View on chart |
| AXTI | ▲ Buy | Grant | 29,112 | — | 7/29/2025 | View on chart |
| AXTI | ▲ Buy | Grant | 18,306 | $0 | 1/3/2023 | View on chart |
| AXTI | ▲ Buy | Grant | 1,436 | $0 | 1/3/2022 | View on chart |
| AXTI | ▲ Buy | Grant | 7,827 | $0 | 12/29/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
AXT Stock Drops 10% Despite Analysts Doubling 2027 Revenue Estimates
AXT shares fell 10% in a single day even as analysts raised 2027 revenue forecasts by more than double. The move comes after a month of 21% gains, showing volatility. Analysts see surging indium phosphide demand as a potential long‑term growth driver for the company.
AXT Stock Drops 10% Despite Analysts Doubling 2027 Revenue Estimates. AXT shares fell 10% in a single day even as analysts raised 2027 revenue forecasts by more than double. The move comes after a month of 21% gains, showing volatility. Analysts see surging indium phosphide demand as a potential long‑term growth driver for the company.